Cargando…
A Novel ALDH1A1 Inhibitor Targets Cells with Stem Cell Characteristics in Ovarian Cancer
A small of population of slow cycling and chemo-resistant cells referred to as cancer stem cells (CSC) have been implicated in cancer recurrence. There is emerging interest in developing targeted therapeutics to eradicate CSCs. Aldehyde-dehydrogenase (ALDH) activity was shown to be a functional mark...
Autores principales: | Nwani, Nkechiyere G., Condello, Salvatore, Wang, Yinu, Swetzig, Wendy M., Barber, Emma, Hurley, Thomas, Matei, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521036/ https://www.ncbi.nlm.nih.gov/pubmed/30965686 http://dx.doi.org/10.3390/cancers11040502 |
Ejemplares similares
-
The hunt for elusive cancer stem cells
por: Condello, Salvatore, et al.
Publicado: (2017) -
Intracellular optical doppler phenotypes of chemosensitivity in human epithelial ovarian cancer
por: Li, Zhe, et al.
Publicado: (2020) -
Beta-Catenin Regulated ALDH1A1 is a Target in Ovarian Cancer
Spheroids
por: Condello, Salvatore, et al.
Publicado: (2014) -
Targeting the Microenvironment in High Grade Serous Ovarian Cancer
por: Nwani, Nkechiyere G., et al.
Publicado: (2018) -
A Novel ALDH1A1 Inhibitor Blocks Platinum-Induced Senescence and Stemness in Ovarian Cancer
por: Muralikrishnan, Vaishnavi, et al.
Publicado: (2022)